Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-29

Clinical Trial Update: Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of Bifidobacterium quadruple live tablets in patients with Type 2 Diabetes Mellitus with constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium quadruple live tablets (Bifidobacterium quadruple live tablets)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Type 2 Diabetes Mellitus With Complication | Phase 4 | Status: UNKNOWN